Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 19 years or older
- People who have been found to have, or are suspected of having, stage IV lung cancer (the most advanced stage) based on medical imaging and clinical assessment, either with or without a tissue sample confirming the diagnosis
- People who are already scheduled to have a bronchoscopy procedure with lung fluid collection (a camera procedure into the airways with fluid sampling) as part of their normal medical care
- People who are willing and able to sign a written consent form agreeing to take part
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have received treatment for an active lower lung infection (such as pneumonia or a fungal lung infection) within the 4 weeks before their bronchoscopy procedure
- People who have previously had an organ transplant or a stem cell transplant
- People who are currently taking medications that suppress the immune system throughout the whole body
- People who are currently using, or planning to use, biologic drugs that affect how the immune system works
- People who have a known autoimmune disease that requires immune-suppressing medication
- People who are pregnant
- People whose stage IV lung cancer has come back after they previously received treatment intended to cure or fully control it
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82-2-870-2228
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation Between Bronchoalveolar Lavage T-cell Immunophenotypes and Tumor PD-L1 Expression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.